trial · primary record
Semaglutide Injectable Product
HIV/AIDS
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 108 |
| Primary completion | 2026-10-09 |
| Primary endpoint | Effects of Semaglutide on Quantity of Abdominal Fat (Total, Subcutaneous, Visceral) at Week 32 Compared to Baseline |
| Registry ID | NCT04019197 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:57.778Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04019197
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.